Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.

A4M Medicine Redefined

Non-Profit Trusted Source of Non-Commercial Health Information

COVID-19 vaccines a...
 
Notifications
Clear all

COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals

1 Posts
1 Users
0 Reactions
79 Views
Posts: 1
Guest
Topic starter
(@Dr. Know)
New Member
Joined: 4 weeks ago

Participants included 99,068,901 vaccinated individuals. In total, 183,559,462 doses of BNT162b2, 36,178,442 doses of mRNA-1273, and 23,093,399 doses of ChAdOx1 were administered across participating sites in the study period. Risk periods following homologous vaccination schedules contributed 23,168,335 person-years of follow-up. OE ratios with LBCI > 1.5 were observed for Guillain-Barré syndrome (2.49, 95 % CI: 2.15, 2.87) and cerebral venous sinus thrombosis (3.23, 95 % CI: 2.51, 4.09) following the first dose of ChAdOx1 vaccine. Acute disseminated encephalomyelitis showed an OE ratio of 3.78 (95 % CI: 1.52, 7.78) following the first dose of mRNA-1273 vaccine. The OE ratios for myocarditis and pericarditis following BNT162b2, mRNA-1273, and ChAdOx1 were significantly increased with LBCIs > 1.5.

https://pubmed.ncbi.nlm.nih.gov/38350768/

Leave a reply

Author Name

Author Email

Title *

My Media   or drag and drop it here. Max file size 50MB
 
Preview 0 Revisions Saved